Common Questions

Myopia, commonly called nearsightedness, is a vision condition where close objects appear clear but distant objects appear blurry. It occurs when the eye grows too long from front to back, causing light to focus in front of the retina instead of directly on it.

Childhood myopia tends to progress (get worse) until early adulthood. Higher levels of myopia significantly increase the risk of serious eye conditions later in life, including retinal detachment, glaucoma, cataracts, and myopic maculopathy. Early intervention can help slow this progression.

Myopia is caused by a combination of genetic and environmental factors. Children with myopic parents are at higher risk. Environmental factors include excessive near work (reading, screens), limited outdoor time, and starting school at a young age.

Myopia typically begins between ages 6-14, though it can start earlier or later. Earlier onset often leads to higher final prescription levels, which is why early detection and management are important.

myopia control refers to treatments specifically designed to slow the progression of myopia in children, not just correct their vision. These include orthokeratology (Ortho-K), MiSight contact lenses, low-dose atropine drops, and specialized spectacle lenses.

Research shows that myopia management treatments can slow progression by 50-60% on average. Ortho-K and low-dose atropine both show approximately 50-60% efficacy, while MiSight lenses have shown 59% reduction in axial length growth in clinical trials.

Yes, Ortho-K is considered safe for children when properly fitted and cared for. The lenses are FDA-approved and have been used for decades. The key is proper hygiene, following wear schedules (5-6 hours nightly), and regular follow-up visits with your eye care provider.

At low concentrations (0.01%-0.05%), atropine has minimal side effects. Some children may experience mild light sensitivity or difficulty focusing up close, but these effects are typically minor and temporary. Higher concentrations have more noticeable side effects.

Yes, some eye care providers recommend combining treatments for enhanced effect. For example, low-dose atropine can be used alongside Ortho-K or MiSight lenses. Your myopia specialist can advise on the best approach for your child.

Use our Find a Specialist directory to locate eye care professionals who specialize in myopia control. Look for providers who offer multiple treatment options and have experience with pediatric patients. Ask about their training and the technologies they use.

Key questions include: What is my child's current prescription and axial length? How quickly is their myopia progressing? What treatment options do you recommend and why? What is the expected efficacy? How often will we need follow-up visits?

Coverage varies by insurance plan. Some vision plans cover a portion of specialty contact lenses or Ortho-K. Atropine drops may be covered under medical insurance. We recommend contacting your insurance provider and asking your eye care office about payment options.

Children with myopia should typically have eye exams every 6 months during active progression years. Your eye care provider may recommend more or less frequent visits based on your child's specific situation and treatment plan.

Yes! Research shows that spending 2+ hours outdoors daily can reduce the risk of myopia onset by up to 50%. The bright light outdoors is believed to trigger dopamine release in the retina, which helps regulate eye growth.

While screen time alone doesn't cause myopia, excessive near work (including screens) is associated with increased risk. Encourage the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds. Balance screen time with outdoor activities.

Reading itself doesn't cause myopia, but prolonged near work is a risk factor. Encourage good reading habits: proper lighting, holding books at arm's length, taking regular breaks, and balancing reading with outdoor time.

The 20-20-20 rule is a simple guideline to reduce eye strain: every 20 minutes of near work, look at something 20 feet away for at least 20 seconds. This helps relax the focusing muscles in the eyes and may help reduce myopia progression risk.

Yes, specialized spectacle lenses like MiyoSmart (DIMS technology) and Stellest have been shown to slow myopia progression by 50-60% in clinical trials. These lenses use special optical designs to reduce the stimulus for eye elongation while providing clear vision.

Costs vary by treatment type and location. Ortho-K typically costs $1,000-$2,500 for the first year including fitting, lenses, and follow-up visits, then $300-$600 annually for replacements. MiSight lenses cost around $500-$1,000 per year. Low-dose atropine drops are generally $30-$100 per month depending on pharmacy and concentration.

Coverage varies significantly by plan. Some vision plans cover specialty contact lenses partially. Medical insurance may cover atropine as a prescription medication. Many providers offer payment plans. Always check with both your vision and medical insurance, and ask your provider about financing options.

Many parents and eye care professionals believe the investment is worthwhile because slowing myopia progression reduces the lifetime risk of serious eye conditions. High myopia significantly increases risks of retinal detachment, glaucoma, cataracts, and myopic maculopathy. Take our Risk Assessment to understand your child's risk level. The cost of managing these conditions later in life can be substantial.

Low-dose atropine is often the most affordable option, especially at lower concentrations. Some providers offer payment plans for Ortho-K. Specialized spectacle lenses may be partially covered by vision insurance. Outdoor time (2+ hours daily) is free and has been shown to help prevent myopia onset.

Ortho-K costs typically include: initial comprehensive eye exam, corneal topography mapping, custom lens fitting, the lenses themselves, follow-up visits (usually several in the first few months), and adjustments as needed. Annual costs after the first year include replacement lenses and monitoring visits.

myopia control is typically continued until myopia progression naturally slows, usually in the late teens to early twenties. Treatment duration depends on when myopia started, how quickly it's progressing, and individual factors. Your eye care provider will monitor progression and recommend when to consider stopping.

myopia control slows progression but doesn't stop it completely. Most children will still experience some increase in their prescription, but typically 50-60% less than without treatment. The goal is to reduce the final level of myopia and associated health risks.

For Ortho-K, vision improvement is often noticeable within days to weeks. For measuring slowed progression, it typically takes 6-12 months to see meaningful differences compared to expected progression. Your provider will track axial length and prescription changes over time.

If treatment is stopped before myopia naturally stabilizes, progression may resume at the previous rate. Some studies suggest there may be a temporary "rebound" effect with certain treatments. Decisions to stop treatment should be made with your eye care provider based on age and progression patterns.

Yes! Ortho-K is particularly popular among young athletes because it provides clear daytime vision without glasses or contacts. MiSight and atropine users can wear their lenses or use drops as prescribed and participate in sports normally. Discuss any specific concerns with your eye care provider.

Yes, when properly supervised. Ortho-K and MiSight are FDA-approved for children as young as 8. Low-dose atropine has been used safely in children for decades. The key factors are proper fitting, good hygiene habits, and regular follow-up visits. Your provider will assess if your child is a good candidate.

The best treatment depends on your child's age, prescription, lifestyle, and ability to handle contact lenses or eye drops. Ortho-K works well for active children who don't want daytime glasses. MiSight is good for children comfortable with daily contact lens wear. Atropine is ideal for those who prefer drops over contacts. Many specialists recommend combining treatments for enhanced effect.

Ortho-K uses rigid lenses worn overnight to temporarily reshape the cornea, providing clear daytime vision without glasses or contacts. MiSight are soft daily disposable lenses worn during the day. Both show similar efficacy (50-60% slowing). Ortho-K requires more careful hygiene; MiSight is simpler to use but requires daytime wear. See our side-by-side comparison for more details.

Yes, low-dose atropine can be combined with Ortho-K or MiSight lenses for potentially enhanced myopia control. Some studies suggest combination therapy may be more effective than either treatment alone. Your eye care provider can advise on the best combination approach for your child.

Recent studies show specialized spectacle lenses (like MiyoSmart and Stellest) can slow myopia progression by 50-60%, similar to contact lens options. They may be a good choice for children not ready for contact lenses or those who prefer glasses. Effectiveness depends on consistent full-time wear.